{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T02:17:02Z","timestamp":1768443422547,"version":"3.49.0"},"reference-count":25,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>More than 30 million people in the US take prescribed benzodiazepines, which, when taken long-term, carry risks of falls, cognitive decline, and dependence. A previous trial showed that a patient-focused self-management intervention (Eliminating Medications Through Patient Ownership of End Results; EMPOWER) can reduce long-term benzodiazepine dependence use and the risks that accompany it.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To replicate the finding of the EMPOWER trial after converting the intervention from printed materials to electronic format.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This 2-arm, individually randomized clinical trial with a 6-month follow-up was conducted at US Veterans Health Administration primary care clinics in 2 Veterans Affairs health care systems. Participants included 161 primary care patients taking benzodiazepines for 3 or more months and having access to a smartphone, tablet, or desktop computer. Recruitment occurred from June 1, 2022, to January 31, 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Participants were randomized to either the electronically delivered EMPOWER (EMPOWER-ED) protocol or asked to continue to follow clinician recommendations regarding their benzodiazepine use (treatment as usual).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Preregistered primary outcomes were complete benzodiazepine cessation and at least 25% dose reduction at 6-month follow-up, assessed using pharmacy data. Secondary outcomes were self-reported anxiety symptoms, sleep quality, and overall health and quality of life. Analysis was performed on an intent-to-treat basis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The 161 participants had a mean (SD) age of 61.9 (13.7) years and were mostly male (134 [83.2%]). Individuals assigned to the EMPOWER-ED group had a significantly greater likelihood of complete benzodiazepine cessation (odds ratio [OR], 5.31 [95% CI, 1.12-25.12]). There was no likelihood of at least a 25% dose reduction in the EMPOWER-ED group relative to the control group (OR, 2.51 [95% CI, 0.91-6.90]). No statistically significant difference was found between the 2 groups for the secondary outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>This randomized clinical trial found a large effect of a low-cost, self-administered electronic intervention for reducing benzodiazepine use among long-term users. Findings from this replicated clinical trial are encouraging given the prevalence of benzodiazepine dependence and the constraints on clinician time available to address it. Dissemination of this intervention\u2014which is in the public domain\u2014by health care and public health systems seems warranted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT04572750\">NCT04572750<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.51807","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:00:43Z","timestamp":1768406443000},"page":"e2551807","source":"Crossref","is-referenced-by-count":0,"title":["Electronic Intervention for Patient-Managed Benzodiazepine Tapering"],"prefix":"10.1001","volume":"9","author":[{"given":"Keith","family":"Humphreys","sequence":"first","affiliation":[{"name":"Center for Innovation to Implementation, Veterans Affairs Palo Alto Health Care System, Menlo Park, California"},{"name":"Department of Psychiatry, Stanford University, Stanford, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hildi","family":"Hagedorn","sequence":"additional","affiliation":[{"name":"Center for Care Delivery and Outcomes Research, Minneapolis Veterans Affairs Health Care System, Minneapolis, Minnesota"},{"name":"Department of Psychiatry, University of Minnesota Medical School, Minneapolis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaotong","family":"Han","sequence":"additional","affiliation":[{"name":"Center for Mental Healthcare and Outcomes Research, Central Arkansas Veterans Affairs Healthcare System, North Little Rock"},{"name":"Veterans Affairs South Central Mental Illness Research, Education and Clinical Center, Central Arkansas Veterans Healthcare System, North Little Rock"},{"name":"Department of Psychiatry, University of Arkansas for Medical Sciences, Little Rock"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakiesha","family":"Kemp","sequence":"additional","affiliation":[{"name":"Center for Mental Healthcare and Outcomes Research, Central Arkansas Veterans Affairs Healthcare System, North Little Rock"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nichols","family":"Poitra","sequence":"additional","affiliation":[{"name":"Center for Mental Healthcare and Outcomes Research, Central Arkansas Veterans Affairs Healthcare System, North Little Rock"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Cucciare","sequence":"additional","affiliation":[{"name":"Center for Mental Healthcare and Outcomes Research, Central Arkansas Veterans Affairs Healthcare System, North Little Rock"},{"name":"Veterans Affairs South Central Mental Illness Research, Education and Clinical Center, Central Arkansas Veterans Healthcare System, North Little Rock"},{"name":"Department of Psychiatry, University of Arkansas for Medical Sciences, Little Rock"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"zoi251380r1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2022.106857","article-title":"Opioid tapering support using a web-based app: development and protocol for a pilot randomized controlled trial.","volume":"119","author":"Edmond","year":"2022","journal-title":"Contemp Clin Trials"},{"issue":"7","key":"zoi251380r2","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1037\/adb0000598","article-title":"Using peers to increase veterans\u2019 engagement in a smartphone application for self-management of hazardous drinking: a pilot study of acceptability and utility.","volume":"35","author":"Blonigen","year":"2021","journal-title":"Psychol Addict Behav"},{"issue":"5","key":"zoi251380r3","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1111\/add.15263","article-title":"Electronically-delivered brief alcohol intervention for liver disease patients: a randomized controlled trial.","volume":"116","author":"Cucciare","year":"2021","journal-title":"Addiction"},{"issue":"1","key":"zoi251380r4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/14639230600562816","article-title":"Access to the internet among drinkers, smokers and illicit drug users: is it a barrier to the provision of interventions on the World Wide Web?","volume":"31","author":"Cunningham","year":"2006","journal-title":"Med Inform Internet Med"},{"issue":"2","key":"zoi251380r5","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.8.2.e5","article-title":"Formative evaluation and three-month follow-up of an online personalized assessment feedback intervention for problem drinkers.","volume":"8","author":"Cunningham","year":"2006","journal-title":"J Med Internet Res"},{"issue":"8","key":"zoi251380r6","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.addbeh.2005.03.003","article-title":"Internet and paper self-help materials for problem drinking: is there an additive effect?","volume":"30","author":"Cunningham","year":"2005","journal-title":"Addict Behav"},{"issue":"8","key":"zoi251380r7","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMp1715050","article-title":"Our other prescription drug problem.","volume":"378","author":"Lembke","year":"2018","journal-title":"N Engl J Med"},{"key":"zoi251380r8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e6231","article-title":"Benzodiazepine use and risk of dementia: prospective population based study.","volume":"345","author":"Billioti de Gage","year":"2012","journal-title":"BMJ"},{"issue":"2","key":"zoi251380r9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1365-2125.2012.04418.x","article-title":"Benzodiazepine harm: how can it be reduced?","volume":"77","author":"Lader","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"zoi251380r10","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/add.14886","article-title":"Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine.","volume":"115","author":"Park","year":"2020","journal-title":"Addiction"},{"key":"zoi251380r11","doi-asserted-by":"publisher","first-page":"j760","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis.","volume":"356","author":"Sun","year":"2017","journal-title":"BMJ"},{"issue":"6","key":"zoi251380r13","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","article-title":"Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial.","volume":"174","author":"Tannenbaum","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"4","key":"zoi251380r14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-080109","article-title":"Implementation of an intervention aimed at deprescribing benzodiazepines in a large US healthcare system using patient education materials: a pre\/post-observational study with a control group.","volume":"14","author":"Le","year":"2024","journal-title":"BMJ Open"},{"issue":"9","key":"zoi251380r15","doi-asserted-by":"publisher","DOI":"10.2196\/35514","article-title":"Adapting the Eliminating Medications Through Patient Ownership of End Results protocol to promote benzodiazepine cessation among US military veterans: focus group study with US military veterans and national Veterans Health Administration leaders.","volume":"24","author":"Cucciare","year":"2022","journal-title":"J Med Internet Res"},{"key":"zoi251380r16","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2022.100994","article-title":"Promoting benzodiazepine cessation through an electronically-delivered patient self-management intervention (EMPOWER-ED): randomized controlled trial protocol.","volume":"29","author":"Cucciare","year":"2022","journal-title":"Contemp Clin Trials Commun"},{"issue":"9","key":"zoi251380r17","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1111\/add.13819","article-title":"Internet interventions for adult illicit substance users: a meta-analysis.","volume":"112","author":"Boumparis","year":"2017","journal-title":"Addiction"},{"issue":"10","key":"zoi251380r18","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7.","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"issue":"1","key":"zoi251380r19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/15402002.2012.636266","article-title":"Development of short forms from the PROMIS sleep disturbance and Sleep-Related Impairment item banks.","volume":"10","author":"Yu","year":"2011","journal-title":"Behav Sleep Med"},{"issue":"10","key":"zoi251380r20","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1007\/s11606-015-3453-9","article-title":"Linking physical and mental health summary scores from the Veterans RAND 12-Item Health Survey (VR-12) to the PROMIS Global Health Scale.","volume":"30","author":"Schalet","year":"2015","journal-title":"J Gen Intern Med"},{"key":"zoi251380r21","doi-asserted-by":"publisher","journal-title":"Drug Alcohol Depend","DOI":"10.1016\/j.drugalcdep.2018.02.011"},{"issue":"16","key":"zoi251380r22","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","article-title":"The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking.","volume":"158","author":"Bush","year":"1998","journal-title":"Arch Intern Med"},{"issue":"2","key":"zoi251380r23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1046\/j.1360-0443.2000.95224511.x","article-title":"The Severity of Dependence Scale (SDS) as screening test for benzodiazepine dependence: SDS validation study.","volume":"95","author":"de las Cuevas","year":"2000","journal-title":"Addiction"},{"issue":"5","key":"zoi251380r24","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8224","article-title":"Using Generalized Anxiety Disorder-2 (GAD-2) and GAD-7 in a primary care setting.","volume":"12","author":"Sapra","year":"2020","journal-title":"Cureus"},{"issue":"3","key":"zoi251380r25","article-title":"Individual and social benefits of mutual aid self-help groups.","volume":"27","author":"Humphreys","year":"1997","journal-title":"Soc Policy"},{"key":"zoi251380r12","volume-title":"Re-evaluating the Issue of Benzodiazepines: A Focus on High-Risk Populations","author":"VA Academic Detailing Service","year":"2016"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2843881\/humphreys_2026_oi_251380_1767812654.73833.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:00:44Z","timestamp":1768406444000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2843881"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.51807","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]}}}